Jane Street Group, LLC Atea Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022
SELL
$5.5 - $9.19 $755,150 - $1.26 Million
-137,300 Reduced 61.05%
87,600 $632,000
Q4 2021

Feb 15, 2022
BUY
$7.67 - $44.59 $1.58 Million - $9.19 Million
206,100 Added 1096.28%
224,900 $2.01 Million
Q3 2021

Nov 16, 2021
SELL
$21.33 - $35.06 $2,133 - $3,506
-100 Reduced 0.53%
18,800 $659,000
Q2 2021

Aug 16, 2021
BUY
$19.22 - $59.08 $363,258 - $1.12 Million
18,900 New
18,900 $406,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $270M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email